NHS England has written to the majority of patients who are currently eligible for treatments for COVID-19, to inform them the way they access these treatments is changing.

From Tuesday 27 June 2024, eligible patients will be able to self-refer to the COVID Medicines Delivery Unit (CMDU), which provides antiviral medicines to patients who have tested positive for COVID-19 and who identify as belonging to the highest risk clinical subgroup.

This includes some patients with cancer, blood conditions, kidney disease, liver disease and auto-immune diseases, among others.

If you are an eligible patient and test positive for COVID-19, please contact the CMDU directly and self-refer by:

Visiting https://phlgroup.co.uk/cmdu online and completing a self-referral form
Phoning 03300 587080
Patients will be assessed within 24 hours of referral.

Further information is available online: https://www.hantsiowhealthandcare.org.uk/your-health/covid-19/hampshire-and-isle-wight-covid-medicine-delivery-unit-cmdu-service